Biotech Startups

Pasithea is a biotechnology company focused on the discovery and development of therapeutics for central nervous system disorders and RASopathies. Its research targets conditions including Neurofibromatosis type 1 (NF1), ALS, multiple sclerosis, and schizophrenia.

1 investor

Passage Bio is a biotechnology company developing treatments for central nervous system (CNS) diseases, with a focus on neurodegenerative conditions. It works on therapies for patients living or born with CNS diseases and their families.

1 investor

1 investor

Pathios Therapeutics is a drug discovery and development company working on small-molecule drugs that block the immune cell receptor GPR65, which senses the acidic tumor microenvironment, with a lead asset (PTT-4256) aimed at treating solid cancers. The company targets cancer immunotherapy applications across a broad range of solid tumors.

1 investor

Pathnostics is a CAP-accredited and CLIA-certified diagnostics laboratory offering histopathology, cytology, and molecular tests across urology, women's health, and gastroenterology. Its flagship platform, Guidance UTI, combines molecular detection with proprietary Pooled Antibiotic Susceptibility Testing (P-AST) for infectious disease and cancer diagnostics.

1 investor

iDose TR is a treatment for open-angle glaucoma and high eye pressure. The page serves as a patient story collection portal for individuals undergoing treatment.

1 investor

PBD Biotech develops phage-based diagnostics, applying its technology to disease detection across clinical and veterinary applications. The company works in the diagnostics industry with expertise spanning disease management and policy.

1 investor

PBS Biotech develops Vertical-Wheel bioreactors and related accessories for scalable manufacturing of cell therapies, including allogeneic therapies derived from induced pluripotent stem cells, mesenchymal stem cells, and CAR-T or NK cells. It serves cell therapy developers from R&D through clinical trials and commercialization, offering products, consulting packages, and process scale-up support.

1 investor

PCI Biotech develops bioprocessing technologies for manufacturing viral vectors and intracellular drug delivery solutions, serving immunotherapy and dermatology applications.

1 investor

NASDAQ-listed company harnessing immunology for therapeutic development

1 investor

PDS Biotech develops T cell activating immunotherapies for cancer and infectious disease vaccines in clinical stages. The company operates proprietary platforms and maintains partnerships with major healthcare institutions including Merck, MD Anderson Cancer Center, National Cancer Institute, and Mayo Clinic.

1 investor

Pearl Bio develops technologies for genome engineering, ribosome engineering, and biomanufacturing to enable production of novel proteins, chemicals, and materials for biotechnology and medicine.

1 investor

Peer AI builds AI-powered tools for drug development and clinical research, with a focus on medical writing and regulatory work. It serves life sciences and pharma organizations, combining generative AI with expertise in data protection and privacy.

1 investor

Peerbridge Health develops solutions focused on cardiac care and clinical insight.

1 investor

PegBio is a biotech company founded in 2008 that develops innovative therapies for chronic diseases, with a focus on endocrine and metabolic disorders. Using its proprietary HECTOR technology platform, it designs peptide, protein, and small-molecule drug candidates targeting conditions such as type 2 diabetes, obesity, MASH, opioid-induced constipation, and congenital hyperinsulinism.

1 investor

Pelagen engineers animal-free leather by cultivating skin tissue from cells, aiming to match the quality of conventional leather without the environmental or animal-welfare impact. Its biofabricated material targets applications in fashion, automotive, and interiors.

1 investor

Pelagos Pharma develops drugs targeting hard-to-treat receptors for age-related diseases, with a focus on extending healthspan and longevity.

1 investor

Pelton Shepherd provides cold chain packaging solutions and refrigerant expertise to customers requiring temperature-controlled supply logistics. The company operates as a third-generation family business with over 70 years of industry experience.

1 investor

Pending AI develops a drug discovery and development platform using quantum mechanics and artificial intelligence to enable pharmaceutical companies to develop medicines for any disease. The company serves pharmaceutical partners in asset co-development.

1 investor

Pentalink develops a fully automated sericulture system to produce silk fiber as a sustainable natural alternative to petroleum-based synthetic textiles. The company aims to revolutionize silk production through technological innovation in cultivation and processing.

1 investor

LEO Pharma is a global pharmaceutical company specializing in medical dermatology treatments for skin diseases, with additional focus on critical care including thrombosis and immunooncology. The company serves over 100 million patients annually across 70+ countries and employs 4,000 people.

1 investor

Peptron develops long-acting (sustained-release) drug formulations using its proprietary drug delivery system (DDS) technology, including its SmartDepot platform, and provides peptide synthesis services under ISO9001 quality management. The South Korean biopharmaceutical company focuses on patient-friendly therapeutics.

1 investor

Peptron is a Korean pharmaceutical company that develops sustained-release injectable drug formulations using its proprietary SmartDepot ultrasonic spray drying technology to create long-acting microsphere formulations. It operates a GMP-designed manufacturing facility producing SR-exenatide and is developing exenatide as a treatment for neurodegenerative disorders under licensed NIH patents.

1 investor

1 investor